Skip To Main Content
Joel Sabaniego on Muck Rack

Joel Sabaniego

As seen in: LinkedIn
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Joel

Contact Joel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

#marketaccess #mfn #p #healthpolicy

|
By Ariel Hammerman, Joel Sabaniego
| LinkedIn
On 12 May 2025, the US administration brought Most-Favoured-Nation pharmaceutical pricing back onto the policy agenda. In the 15 months since then, we have seen the 19 countries that are part of the basket in at least one of the MFN price models respond in different ways. The UK has negotiated: committing to increase net prices for new medicines by 25%, changing NICE’s cost-effectiveness range and limiting rebates—in exchange for trade and MFN-related protections.
Open in Who Shared Issue with article?
See all 1 articles